ISPECTAMAB TAZIDE
UNII 6T0D8LA4M5

Substance Identification & Data

This profile provides standardized clinical and technical data for Ispectamab Tazide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6T0D8LA4M5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2585651-78-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
6T0D8LA4M5
CAS Registry Number
2585651-78-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ISPECTAMAB TAZIDE
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C190324
National Cancer Institute reference terminology for clinical and research data.
INN ID
12139
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ispectamab Tazide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ISPECTAMAB TAZIDE

Common Names & Synonyms

IMMUNOGLOBULIN G1 (186,410-BIS(4-(AZIDOMETHYL)-L-PHENYLALANINE)), ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY PROTEIN TNFRSF17) (HUMAN-MUS MUSCULUS MONOCLONAL SP8893 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SP8893 .KAPPA.-CHAIN, DIMER
ISPECTAMAB TAZIDE [INN]

Technical Codes

SP-8893

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus